increasing progression 中文意思是什麼

increasing progression 解釋
遞增級數
  • increasing : adj. 增加的，增大的。
  • progression : n. 1. 前進，進行。2. 〈罕用語〉進步，改進，發展；進展狀態。3. 【數學】級數；【音樂】（樂音或和弦的）相繼進行；（各聲部的）和諧進行。adj. -al
  1. The programmed strategy of qim ' s access to available and steady development is : increasing mining production capacity and economic benefits by booming mine through science and technology to achieve increased capacity of continuous progression ; enhancing the ore reserve storage by excavating the prospecting potency of mineral resource ; magnifying scale beneficial result by enlarging output capacity ; adding products with high additional value by progressing towards futhur processing mineral products ; meanwhile, saving the management risk by developing non - steel industry ; concentrating the main body to increase the benefits by separating the subsidiary from the main one and staffs being laid of ; seeking supports of mining industry economic policy from macroeconomic policy to lighten the burden of our enterprise ; dealing well with the problem of guaranteeing the life of the staff being separated for further steadying circumstance of enterprise and society and perfectly realizing the constant development of qim

    規劃的齊大山鐵礦可持續發展戰略是：通過科技興礦來提高采礦的生產能力和經濟效益，達到可持續發展能力的提高；通過挖掘齊礦礦產資源的勘探潛力來提高后備資源的儲備；通過擴大產量規模來增大規模效益；通過礦產品向深加工方向發展來增加高附加值產品；同時，發展非鋼產業來降低企業的經營風險；通過實施主附分離來精幹主體、減員增效。從宏觀經濟政策上來尋求礦業經濟政策的支持，減輕企業的負擔；為了使企業和社會的環境更加穩定，要解決分流人員的生活保障問題，從而更好的實現齊礦的可持續發展。
  2. Introduction protein kinase c ( pkc ) is a number of serine / threonine kinase family which play central regulatory roles in a multitude of cellular processes, including cell proliferation, cell cycle progression, differentiation, apoptosis. increasing evidence from studies using in vitro and in vivo systems suggests that pkc is a key regulator of critical cell cycle transitions, including cell cycle entry and exit and the gl and g2 checkpoint

    前言細胞周期是細胞增殖、分化的一個重要過程，它的啟動與進程受到嚴格調控，參與調控的因子不僅包含起正調控作用的細胞周期素（ cyclins ） 、細胞周期蛋白依賴性激酶（ cyclin - dependentkinase ， cdk ） 、還有起負調控作用的cdk抑制因子（ cyclin - dependentkinaseinhibitor ， cki ） 。
  3. New york ( reuters health ) jan 17 - increasing the planned dose intensity of cisplatin and doxorubicin for osteosarcoma may improe the histologic response, but it does not increase progression - free or oerall surial, new research suggests

    據1月17日路透社健康新聞報道，新的研究成果顯示，增加骨肉瘤患者應用順鉑和阿黴素的常規化療計量，雖然可以改善組織學反應，但並不能控制疾病發展或提高總生存率。
分享友人
分享到 Line

分享到臉書